ReviewPolymers2025
Polymeric Materials in Biomedical Engineering: A Bibliometric Mapping.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Special Issue "Development, Characterization and Applications of Novel Polymeric Materials and Composites".International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study offers an integrated synthesis of polymeric materials in biomedical engineering, revealing four major and interlinked research domains: tissue engineering and regenerative medicine, drug delivery and nanomedicine, wound healing and antimicrobial applications, and advanced fabrication through 3D/4D printing and bioprinting. Across these areas, hydrogels, biodegradable composites, and stimuli-responsive polymers emerge as the most influential material classes. The analysis highlights substantial progress in extracellular matrix-mimetic scaffolds, smart drug delivery systems with controlled release, multifunctional wound dressings integrating antimicrobial and healing functions, and patient-specific constructs produced via additive manufacturing. Despite these advances, recurring challenges persist in long-term biocompatibility and safety, scalable and reproducible fabrication, and regulatory standardisation. The results point toward a convergence of bioactivity, manufacturability, and clinical translation, with hybrid natural-synthetic systems and personalised polymeric designs defining the next phase of biomedical polymer innovation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.